CreditReports.dk
HomeScreen companies

BioNordic A/S Financials, key figures and credit report

CVR number: 40831622 Established 2019 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Borupvang 3, 2750 Ballerup stefan.michelsen@bio-nordic.com tel: 20946876 bio-nordic.com
Gross profit 49 188.8 kDKK FY 2025 -16.9% vs 2024
EBIT 12 446.5 kDKK FY 2025 -5.1% vs 2024
Net debt 15 790.3 kDKK FY 2025 -91.3% vs 2024
Quick ratio 0.7 FY 2025 +0.3 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit40 331.9777 810.0095 559.1259 211.7749 188.84
Employee benefit expenses-24 629.52-35 502.23-38 585.76-34 893.78-30 676.62
Other operating expenses- 856.18-13 719.53-43.48- 105.02
Total depreciation-21 571.42-9 561.08-13 367.45-11 098.52-6 065.75
EBIT-6 725.1619 027.1643 562.4313 114.4612 446.47
Other financial income20 164.62478.005 514.73896.961 152.66
Other financial expenses-8 385.98-8 208.68-15 173.14-22 325.28-10 140.89
Net income from associates (fin.)129 829.69
Pre-tax profit5 053.4811 296.4833 904.02-8 313.86133 287.93
Income taxes-4 645.27-6 139.63-9 355.44-12 546.63-1 585.72
Net earnings408.205 156.8524 548.58-20 860.48131 702.21

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights5 900.984 178.973 623.93521.83358.90
Goodwill615.9430 967.6328 313.8127 463.54665.94
Intangible assets total6 516.9235 146.6031 937.7427 985.371 024.84
Land and waters15 295.8613 898.6014 962.7117 831.1225 511.78
Buildings2 922.464 775.694 723.293 595.407 244.72
Machinery and equipment6 218.497 579.456 679.3410 904.057 432.73
Advance payments and construction in progress1 973.88272.224 559.08
Tangible assets total26 410.6926 525.9730 924.4232 330.5740 189.23
Investments total975.502 750.013 030.213 156.092 430.32
Non-current loans receivable24.00
Non-current other receivables1 435.001 480.00
Long term receivables total24.001 435.001 480.00
Raw materials and consumables72 688.99113 309.79118 855.50110 068.7049 404.65
Finished products/goods92 473.40130 172.64150 387.57156 491.39103 403.63
Inventories total165 162.39243 482.43269 243.07266 560.09152 808.28
Current trade debtors34 624.2162 385.1142 173.2827 448.2919 958.94
Prepayments and accrued income1 371.83306.08401.73
Current other receivables3 680.842 793.2414 290.4812 325.953 288.09
Current deferred tax assets3 434.20
Short term receivables total38 305.0565 178.3557 835.5940 080.3127 082.96
Cash and bank deposits15 258.5320 993.8020 951.0423 309.4014 154.54
Cash and cash equivalents15 258.5320 993.8020 951.0423 309.4014 154.54
Balance sheet total (assets)252 629.08394 101.16413 922.08394 856.83239 170.17

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital500.00500.00500.00500.00500.00
Other reserves5 941.236 996.50
Retained earnings17 302.3419 171.3523 822.7245 443.7824 583.29
Profit of the financial year408.205 156.8524 548.58-20 860.48131 702.21
Shareholders equity total18 210.5424 828.2148 871.3031 024.52163 782.00
Provisions8 919.2413 238.41913.88913.88268.73
Non-current loans from credit institutions21 989.2422 433.9319 130.3716 561.9418 039.82
Non-current owed to group member96 930.31116 776.48181 823.62179 658.16
Non-current liabilities total118 919.55139 210.42200 953.98196 220.1018 039.82
Current loans from credit institutions12 003.646 032.668 965.989 327.1111 905.02
Current trade creditors49 906.53133 879.9759 702.7534 888.169 985.37
Short-term deferred tax liabilities5 437.01594.6211.39338.190.34
Other non-interest bearing current liabilities39 232.5776 316.8794 502.80122 144.8635 188.89
Current liabilities total106 579.75216 824.13163 182.92166 698.3357 079.62
Balance sheet total (liabilities)252 629.08394 101.16413 922.08394 856.83239 170.17
Page generated